$PMNeutralLow

Natixis Advisors LLC Sells 73,389 Shares of Philip Morris International Inc. $PM

Natixis Advisors LLC reduced its Philip Morris International (PM) stake by 5.2% in Q4, selling 73,389 shares to hold 1,346,667 shares, worth about $216.0M (0.09%), per its latest SEC Form 13F. Other institutions also adjusted positions. Analysts cited include Needham ($200 target, buy) and UBS (neutral, $168). PM reported Q1 EPS $1.96 vs $1.83 expected on $10.15B revenue, and set FY2026 EPS guidance of 8.360–8.510.

5/10
4/10
Low
Neutral
post-close/after-hours read-through from latest 13F filing context
Neutral to slightly negative (institutional trim) but outweighed by generally supportive analyst coverage and recent fundamentals cited.

13F selling by a large institutional holder is a mild negative signal, but the article provides no fundamental trigger (no earnings/guidance change tied to PM).

Natixis Advisors trimmed its Philip Morris International stake by 5.2% via a 13F sale of 73,389 shares, signaling institutional positioning change.

Low near-term impact; any move is more likely sentiment/positioning-driven than fundamentals.

Background

The piece summarizes a 13F filing showing Natixis Advisors LLC reduced its PM position, alongside other institutional activity and analyst target updates.

Why it matters

For trading, the actionable element is the ownership change; however, 13F data is backward-looking and typically lower signal than earnings, guidance, or regulatory/product news.

Market relevance

Institutional selling is a modest sentiment input, but the article lacks a fresh fundamental catalyst for PM.

Market effects

Institutional positioning in large-cap tobacco can influence sentiment around defensives, but this is single-firm 13F noise without sector-wide catalyst.

Primarily US large-cap defensive sentiment; limited spillover beyond tobacco/consumer staples.

PM’s global footprint means any sustained ownership trend could reflect broader international tobacco risk appetite, but this article is not evidence of a global shift.

Alternative perspectives

The trim could be rebalancing, tax/mandate changes, or risk control rather than a bearish view on PM fundamentals.

The article also cites recent analyst price targets and PM’s prior earnings/guidance; without a new PM-specific event, traders may overreact to 13F flows.

Key entities

  • Philip Morris International Inc.

    Subject of the article; PM stake trimmed by Natixis Advisors via 13F.

  • Natixis Advisors LLC

    Reported 5.2% reduction in PM holdings in the latest 13F period.

Related articles

$PANWMedAI 8/10

Dow Jones Top Company Headlines at 7 PM ET: SpaceX Eyeing Roughly $1. 75 Trillion Valuation in IPO Next Week | Palo...

SpaceX is reportedly seeking about a $1.75 trillion valuation in an IPO next week, with banks expected to earn hundreds of millions in fees. Palo Alto Networks said revenue rose as customers boosted cyber defenses. GameStop posted higher profit and launched a $2 billion buyback. GitLab plans to cut 14% of staff and exit 22 countries. Other items include Shake Shack cutting guidance and UniCredit advancing a Commerzbank takeover bid.

$PMMedAI 9/10

Philip Morris Shares Ease After Company Trims 2026 Earnings Outlook (PM)

Philip Morris International shares fell about 1% premarket after the company trimmed its 2026 adjusted EPS outlook, citing an expected ~$500 million non-cash impairment tied to its RBH investment and currency headwinds. PM now forecasts 2026 adjusted EPS of $8.31–$8.46 (vs $8.36–$8.51). Reported diluted EPS is $7.18–$7.33; Q2 adjusted diluted EPS $1.97–$2.02.

$PMLow

Is Philip Morris Stock Underperforming the Dow?

Philip Morris International (PM), with a $276.5 billion market cap, is trading 8.1% below its 52-week high of $193.05 (May 19). PM is up 5.1% over three months versus the Dow’s 4.2%, and up 10.6% YTD versus 6.2% for the Dow, but down slightly over 52 weeks versus the Dow’s 21.2%. The FDA guidance on May 11 supported shares. Analysts rate PM “Moderate Buy” (13 analysts) with a $196.08 mean target.